{"id":"W1989963052","doi":"10.3109/10428194.2011.555892","title":"Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group","year":2011,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Neutropenia; Internal medicine; Refractory (planetary science); Pharmacodynamics; Diffuse large B-cell lymphoma; Oncology; Phases of clinical research; Toxicity; Clinical trial; Febrile neutropenia; Lymphoma; Gastroenterology; Pharmacokinetics; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005229506,0.001333416,0.002597342,0.0005157475,0.0004486871,0.0008051781,0.0006749256,0.001130064,0.001570382],"category_scores_gemma":[0.001688894,0.0005002808,0.001115223,0.0004774673,0.0008212368,0.0007449122,0.0002392022,0.001762339,0.0003620831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000938513,"about_ca_system_score_gemma":0.001255914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000725642,"about_ca_topic_score_gemma":0.001675454,"domain_scores_codex":[0.9986916,0.0009078645,0.00007328859,0.0001198304,0.0001039129,0.000103399],"domain_scores_gemma":[0.9988494,0.0002554663,0.0002655712,0.00009238796,0.00008092677,0.0004561833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7523625,0.054483,0.01766764,0.001072503,0.00242241,0.000400969,0.0003459702,0.002999377,0.03770364,0.0003552382,0.004039342,0.1261473],"study_design_scores_gemma":[0.6967031,0.2759942,0.01955041,0.00002891872,0.0006533818,0.000420354,0.00004621904,0.001600618,0.002725875,0.0001381654,0.00210758,0.00003121077],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993103,0.003717408,0.0003554041,0.0003556648,0.00005894184,0.001246433,0.0004135281,0.00004600084,0.0007035293],"genre_scores_gemma":[0.9921566,0.002519061,0.001198652,0.0004304034,0.0001821937,0.001656713,0.001125371,0.00001956998,0.0007114937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005229506,"threshold_uncertainty_score":0.02765661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09485852275559409,"score_gpt":0.3912644948390851,"score_spread":0.296405972083491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}